Trial Profile
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Sep 2022
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Bortezomib; Daratumumab; Ixazomib; Lenalidomide; Levofloxacin
- Indications Pneumococcal infections
- Focus Therapeutic Use
- 28 Aug 2022 Status changed from recruiting to completed.
- 01 Sep 2020 Planned End Date changed from 31 Jul 2020 to 31 Dec 2020.
- 01 Sep 2020 Planned primary completion date changed from 31 May 2020 to 30 Nov 2020.